JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02161 JBM HEALTHCARE

Market Closed 04-17 16:08:09

2.080

-0.010

-0.48%

High2.090	Low2.030	Vol679.59K
Open2.030	D1 Closing2.090	Amplitude2.87%
Mkt Cap1.71B	Tradable Cap1.71B	Total Shares822.00M
T/O1.40M	T/O Rate0.08%	Tradable Shares822.00M
P/B1.69	ROE16.24%	EPS0.15
52wk High2.130	52wk Low0.800	P/E14.09
Dividend0.10	Div.Yield0.05	ROA8.54%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02161","market":"HK","secType":"STK","nameCN":"JBM HEALTHCARE","latestPrice":2.08,"timestamp":1744877289029,"preClose":2.09,"halted":0,"volume":679590,"delay":0,"floatShares":822000000,"shares":822000000,"eps":0.147633,"marketStatus":"Market Closed","change":-0.01,"latestTime":"04-17 16:08:09","open":2.03,"high":2.09,"low":2.03,"amount":1404020,"amplitude":0.028708,"askPrice":2.08,"askSize":238000,"bidPrice":2.07,"bidSize":28000,"shortable":0,"etf":0,"ttmEps":0.194757,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1612454400000,"exchange":"SEHK","adjPreClose":2.09,"dividendRate":0.045913,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.20688415637402247,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02161","defaultTab":"news","newsList":[{"id":"2524253726","title":"JBM (Healthcare) Unit Buys 90% Stake in Medicine Maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253726","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253726?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 19:44","pubTimestamp":1743680662,"startTime":"0","endTime":"0","summary":"JBM   unit Arrow King completed the acquisition of a 90% equity stake in Tin Hee Tong Medicine Factory for HK$171 million, a Thursday filing with the Hong Kong bourse said.The parties had entered into the purchase agreement in February.Tin Hee Tong Medicine Factory engages mainly in the manufacture, marketing, and sales of proprietary Chinese medicine Tin Hee Tong Tin Hee Pills.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MKR.USD.CC","BK4137","MKR.USD.HKCC","BK1191","BK1606","HCSG","02161"],"gpt_icon":0},{"id":"2513728728","title":"JBM (Healthcare) Unit to Buy 90% Stake in Medicine Maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2513728728","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513728728?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 20:17","pubTimestamp":1740399467,"startTime":"0","endTime":"0","summary":"JBM   unit Arrow King agreed to acquire a 90% equity stake in Tin Hee Tong Medicine Factory from Hou Jiasheng for HK$171 million, a Feb. 21 filing with the Hong Kong bourse said.Following completion, Yang QiCheng David, who owns the remaining 10% shares in Tin Hee Tong Medicine Factory will enter into a right of first refusal contract with the buyer.Under the agreement, if Yang plans to dispose of part or all of his stake in the target, he will first offer to sell the shares to the Arrow King.Tin Hee Tong Medicine Factory engages mainly in the manufacture, marketing, and sales of proprietary Chinese medicine Tin Hee Tong Tin Hee Pills.The acquisition will allow the medicine distributor to expand its portfolio of proprietary Chinese medicines and accelerate its growth strategies.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","MKR.USD.CC","02161","BK1606","BK1191","HCSG","MKR.USD.HKCC"],"gpt_icon":0},{"id":"2513640266","title":"BRIEF-Jbm (Healthcare) To Acquire 90% Of Tin Hee Tong Medicine Factory","url":"https://stock-news.laohu8.com/highlight/detail?id=2513640266","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513640266?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 19:26","pubTimestamp":1740137201,"startTime":"0","endTime":"0","summary":"BRIEF-Jbm (Healthcare) To Acquire 90% Of Tin Hee Tong Medicine FactoryFeb 21 (Reuters) - JBM (Healthcare) 2161.HK:TO ACQUIRE 90% OF TIN HEE TONG MEDICINE FACTORY FOR HK$171 MILLIONFurther company coverage: 2161.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC0XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","BK1191","BK1606"],"gpt_icon":0},{"id":"2513726328","title":"JBM (Healthcare) Ltd - to Acquire 90% of Tin Hee Tong Medicine Factory for HK$171 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726328","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726328?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 18:58","pubTimestamp":1740135492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC0XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02161","BK1606"],"gpt_icon":0},{"id":"2490387054","title":"JBM (Healthcare) H1 Net Income HKD 95.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2490387054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490387054?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 17:45","pubTimestamp":1733996730,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nPLX8A3A8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","02161","BK1191"],"gpt_icon":0},{"id":"2487599629","title":"Is JBM (Healthcare) Limited's (HKG:2161) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?","url":"https://stock-news.laohu8.com/highlight/detail?id=2487599629","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487599629?lang=en_us&edition=full_marsco","pubTime":"2024-11-29 15:07","pubTimestamp":1732864038,"startTime":"0","endTime":"0","summary":"JBM (Healthcare) (HKG:2161) has had a great run on the share market with its stock up by a significant 83% over the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2161/jbm-healthcare-shares/news/is-jbm-healthcare-limiteds-hkg2161-stocks-recent-performance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02161","HCSG","BK1606","BK4137","BK1191"],"gpt_icon":0},{"id":"2484948022","title":"JBM (Healthcare)'s Profit Zooms 53% in Fiscal H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2484948022","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484948022?lang=en_us&edition=full_marsco","pubTime":"2024-11-19 20:17","pubTimestamp":1732018661,"startTime":"0","endTime":"0","summary":"JBM   recorded a 53% rise in attributable profit for the six months ended Sept. 30 to HK$95.9 million from HK$62.5 million in the year-ago period, a Tuesday filing with the Hong Kong bourse stated.Earnings per share were HK$0.1163 in the fiscal first half, up from HK$0.0687 in the corresponding period of fiscal year 2023.The Chinese medicine distributor's revenue rose by 22% to HK$399 million in the interim period from HK$326.8 million a year prior.The firm declared an interim dividend of HK$0.055 per share for the half year, payable Jan. 15, 2025, to shareholders of record on Dec. 20, 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","BK1191","02161","HCSG","BK4137"],"gpt_icon":0},{"id":"2484990718","title":"JBM (Healthcare) H1 Gross Profit HKD 205.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2484990718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484990718?lang=en_us&edition=full_marsco","pubTime":"2024-11-19 17:38","pubTimestamp":1732009112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nPLX4D701C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02161","BK1191","BK1606"],"gpt_icon":0},{"id":"2482744401","title":"JBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2482744401","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482744401?lang=en_us&edition=full_marsco","pubTime":"2024-11-12 14:31","pubTimestamp":1731393060,"startTime":"0","endTime":"0","summary":"JBM's   subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma , for HK$46.2 million, a Tuesday Hong Kong bourse filing said.Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02633","BK1606","BK1191","02161"],"gpt_icon":0},{"id":"2482802187","title":"BRIEF-JBM (Healthcare) Says Units To Sell 100,500 Shares In Li Chung Shing Tong","url":"https://stock-news.laohu8.com/highlight/detail?id=2482802187","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482802187?lang=en_us&edition=full_marsco","pubTime":"2024-11-11 22:36","pubTimestamp":1731335771,"startTime":"0","endTime":"0","summary":"BRIEF-JBM  Says Units To Sell 100,500 Shares In Li Chung Shing TongNov 11  - JBM  Ltd 2161.HK:UNITS TO SELL 100,500 SHARES IN LI CHUNG SHING TONG TO EUROPHARM LABORATOIRES FOR TOTAL HK$46.2 MILLIONFurther company coverage: 2161.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nFWN3MI1Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","02633","BK1191","BK1606"],"gpt_icon":0},{"id":"2482378753","title":"JBM (Healthcare) - Units to Sell 100,500 Shares in Li Chung Shing Tong to Europharm Laboratoires for Total HK$46.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2482378753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482378753?lang=en_us&edition=full_marsco","pubTime":"2024-11-11 22:14","pubTimestamp":1731334446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nFWN3MI1Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02161","BK1606","02633","BK1191"],"gpt_icon":0},{"id":"2481122753","title":"JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2481122753","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481122753?lang=en_us&edition=full_marsco","pubTime":"2024-11-08 08:44","pubTimestamp":1731026660,"startTime":"0","endTime":"0","summary":"JBM (Healthcare) Limited ( HKG:2161 ) shareholders have had their patience rewarded with a 35% share price jump in the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2161/jbm-healthcare-shares/news/jbm-healthcare-limited-hkg2161-stock-rockets-35-but-many-are","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1606","BK4137","02161","HCSG"],"gpt_icon":0},{"id":"2480791270","title":"JBM (Healthcare) Expects at Least 50% Higher H1 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2480791270","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480791270?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 16:46","pubTimestamp":1730450818,"startTime":"0","endTime":"0","summary":"JBM   expects profit attributable to shareholders to increase at least 50% for the six months ended Sept. 30 compared with the corresponding period of the previous year, according to a Friday filing with the Hong Kong bourse.The company attributed the increase in profit to the robust sales momentum of the group's key brands, notably Ho Chai Kung in the branded medicines segment and Po Chai Pills in the proprietary Chinese medicines segment, supported by the sustained growth of the group's concentrated Chinese medicine granules business.The company plans to publish its interim results on Nov. 19.The Medicine company's shares were up about 22% at the close of trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","BK1191","HCSG","02161","BK4137"],"gpt_icon":0},{"id":"2480026211","title":"BRIEF-Jbm (Healthcare) Sees Consol Profit Attributable Increased By Not Less Than 50% YoY For HY","url":"https://stock-news.laohu8.com/highlight/detail?id=2480026211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480026211?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 14:21","pubTimestamp":1730442117,"startTime":"0","endTime":"0","summary":"Nov 1 (Reuters) - JBM (Healthcare)   :   * SEES CONSOL PROFIT ATTRIBUTABLE INCREASED BY NOT LESS THAN 50% YOY FOR HY   * EXPECTED RESULT DUE TO ROBUST SALES MOMENTUM OF GROUP'S KEY BRANDS, OTHERSFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","02161","BK1191"],"gpt_icon":0},{"id":"2480778044","title":"JBM (Healthcare) -  Sees CONSOL Profit Attributable Increased by Not Less Than 50% YoY for Hy","url":"https://stock-news.laohu8.com/highlight/detail?id=2480778044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480778044?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 12:25","pubTimestamp":1730435104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241101:nFWN3M724Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02161","BK1606"],"gpt_icon":0},{"id":"2480304477","title":"JBM (Healthcare) - Expected Result Due to Robust Sales Momentum of Group's Key Brands, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2480304477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480304477?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 12:25","pubTimestamp":1730435104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241101:nFWN3M724Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","02161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1005},{"period":"1month","weight":0.1429},{"period":"3month","weight":0.2381},{"period":"6month","weight":1.1849},{"period":"1year","weight":1.4299},{"period":"ytd","weight":0.0947}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.082196},{"month":2,"riseRate":0.25,"avgChangeRate":-0.019034},{"month":3,"riseRate":0.2,"avgChangeRate":0.005652},{"month":4,"riseRate":0.2,"avgChangeRate":-0.025211},{"month":5,"riseRate":0.75,"avgChangeRate":0.201958},{"month":6,"riseRate":0.5,"avgChangeRate":-0.014312},{"month":7,"riseRate":0,"avgChangeRate":-0.100987},{"month":8,"riseRate":0.25,"avgChangeRate":-0.004892},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005389},{"month":10,"riseRate":0.25,"avgChangeRate":-0.052387},{"month":11,"riseRate":0.5,"avgChangeRate":0.160548},{"month":12,"riseRate":1,"avgChangeRate":0.203977}],"exchange":"SEHK","name":"JBM HEALTHCARE","nameEN":"JBM HEALTHCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JBM HEALTHCARE(02161) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JBM HEALTHCARE,02161,JBM HEALTHCARE股票,JBM HEALTHCARE股票老虎,JBM HEALTHCARE股票老虎国际,JBM HEALTHCARE行情,JBM HEALTHCARE股票行情,JBM HEALTHCARE股价,JBM HEALTHCARE股市,JBM HEALTHCARE股票价格,JBM HEALTHCARE股票交易,JBM HEALTHCARE股票购买,JBM HEALTHCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JBM HEALTHCARE(02161) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}